Cleared Special

K070960 - NOVA STATSTRIP XPRESS GLUCOSE HOSPITAL METER SYSTEM

K070960 is an FDA 510(k) clearance for NOVA STATSTRIP XPRESS GLUCOSE HOSPITAL ..., manufactured by Nova Biomedical Corp.. The device is a Class 2 Chemistry device with product code CGA cleared through the Special 510(k) pathway after a 97-day FDA review.

K070960 · Nova Biomedical Corp. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2007
Decision
97d
Days
Class 2
Risk

K070960 is an FDA 510(k) clearance for the NOVA STATSTRIP XPRESS GLUCOSE HOSPITAL METER SYSTEM. Classified as Glucose Oxidase, Glucose (product code CGA), Class II - Special Controls.

Submitted by Nova Biomedical Corp. (Walham, US). The FDA issued a Cleared decision on July 11, 2007 after a review of 97 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1345 - the FDA in vitro diagnostics and chemistry framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Nova Biomedical Corp. devices

FDA 510(k) Submission Details - K070960

510(k) Number K070960 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 05, 2007
Decision Date July 11, 2007
Days to Decision 97 days
Submission Type Special
Review Panel Chemistry (CH)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
9d slower than avg
Panel avg: 88d · This submission: 97d
Pathway characteristics
Modification to existing cleared device.

CGA Device Classification - Class 2, Special Controls

Product Code CGA Glucose Oxidase, Glucose
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1345
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CGA Glucose Oxidase, Glucose

All 289
Devices cleared under the same product code (CGA) and FDA review panel - the closest regulatory comparables to K070960.
CLEVER CHEK AND AUDIOCHEK BLOOD GLUCOSE MONITORING SYSTEMS, MODEL TD-4237
K081609 · Taidoc Technology Corporation · Jul 2008
GLUCOSURE STAR BLOOD GLUCOSE MONITORING SYSTEM, MODEL AS90000E1
K073648 · Apex BioTechnology Corp. · Apr 2008
EASYRA CLINICAL CHEMISTRY ANALYZER
K070057 · Medica Corp. · Aug 2007
GLUCO TRACK BLOOD GLUCOSE MONITORING SYSTEM
K062799 · Apex BioTechnology Corp. · Feb 2007
NOVA STATSTRIP GLUCOSE HOSPITAL METER SYSTEM
K063821 · Nova Biomedical Corp. · Jan 2007
EASYGLUCO, MODEL IGM-0002 G2
K061431 · U. S. Diagnostics, Inc. · Jan 2007